Chugai Group
|
Contact Us
|
Sitemap
About
About
Company Profile
Our Mission, Vision and Values
Meet Our CEO
Meet Our Chairman
Meet Our Directors
Our History
Chugai Japan
Meet Our CEO
Close X
Science and Technology
Science and Technology
Antibody Engineering Technology
Cyclic Peptide Technology
AAALAC Accreditation
Close X
People
People
Research Division
Admin Division
LabStories
Close X
Careers
Careers
Job Openings
FAQs
Close X
Sustainability
Sustainability
Initiative For Society
Close X
News Room
News Room
News Release
Company Events
Science Events
Media
Company Brochure
Publications
Meeting Conferences
Collaboration
Close X
All
About
About
Company Profile
Our Mission, Vision and Values
Meet Our CEO
Meet Our Chairman
Meet Our Directors
Our History
Chugai Japan
Meet Our CEO
Close X
Science and Technology
Science and Technology
Antibody Engineering Technology
Cyclic Peptide Technology
AAALAC Accreditation
Close X
People
People
Research Division
Admin Division
LabStories
Close X
Careers
Careers
Job Openings
FAQs
Close X
Sustainability
Sustainability
Initiative For Society
Close X
News Room
News Room
News Release
Company Events
Science Events
Media
Company Brochure
Publications
Meeting Conferences
Collaboration
Close X
Chugai Group
|
Contact Us
|
Sitemap
About
Find out more
About
Find out more
Sustainability
Find out more
Sustainability
Find out more
News Releases
Establishment of a Subsidiary in South Korea
Source: Home Page Feed
September 30, 2026
Chugai and InxMed Enter into a Worldwide License Agreement for SPYK04, a RAF-MEK Molecular Glue
Source: Home Page Feed
September 29, 2026
Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA
Source: Home Page Feed
September 28, 2026
More news
Science and Technology
Find out more
Science and Technology
Find out more
Careers at Chugai
Join us
Careers at Chugai
Join us
Videos
CPR celebrates 10th Anniversary
More videos